<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">There has been a shift in the treatment paradigm in childhood cancer from cure towards normality and interprofessional collaboration in childhood cancer research has contributed to this [
 <xref ref-type="bibr" rid="CR2">2</xref>, 
 <xref ref-type="bibr" rid="CR3">3</xref>]. Four out of five children with cancer will survive [
 <xref ref-type="bibr" rid="CR4">4</xref>], but half of all children with acute lymphoblastic leukaemia are still affected by at least one of 14 severe toxic, treatment-related side effects [
 <xref ref-type="bibr" rid="CR5">5</xref>]. Moreover, the burden of mortality in childhood cancer survivors is high and continues in adulthood [
 <xref ref-type="bibr" rid="CR6">6</xref>].
</p>
